December 14, 2011

Are You Dense, Inc. Founder Nancy M. Capello, Ph.D. Receives SuperSonic Imagine's 2nd Annual Aixplorer Achievement Award.

Chicago, Illinois  (December 14, 2011) SuperSonic Imagine, the ultrasound company that pioneered breakthrough ShearWave™ Elastography technology (SWE™), and UltraFast™ Doppler, today announced that women’s breast cancer activist Dr. Nancy M. Cappello, President and Founder of Are You Dense, Inc. has received the company’s 2011 Aixplorer Achievement Award.  Cappello is the second recipient of the award following Sherry Lansing who received the award last year.

The SuperSonic Imagine Aixplorer Achievement Award was created to recognize, honor and celebrate the outstanding contribution of time, leadership or financial support made by individuals, companies or associations, to advance cancer research and awareness.

 

August 26, 2011

SuperSonic Imagine Unites Color Flow Imaging with Pulsed Wave Doppler to create UltraFast Doppler, the Company’s Second Revolutionary Breakthrough in Ultrasound Imaging

The Highly Innovative Ultrasound Company Continues to Bring Unmatched Capabilities to its Aixplorer System- Reaching New Imaging Paradigms Unattained by Major Manufacturers.

March 7, 2011

Aixplorer MultiWave™ Technology brings physicians unrivalled diagnostic confidence with its new 3D breast imaging package.

With its unique ShearWave™ Elastography, the Aixplorer ultrasound system exploits two types of waves; one ultrasound wave to ensure impeccable image quality in B-mode, and one shear wave to measure and display true local tissue elasticity in kilopascals.
SuperSonic Imagine presents, for the first time at the ECR, its new 3D breast package.

March 7, 2011

After breast, thyroid and abdomen, SuperSonic Imagine enlarges the clinical applications of its MultiWaveTM ultrasound system Aixplorer with new, dedicated packages: prostate, gynaecology, musculoskeletal and 3D breast.

With its unique ShearWave™ Elastography, Aixplorer exploits two types of waves; one ultrasound wave to ensure impeccable image quality in B-mode, and one shear wave to measure and display true local tissue elasticity in kilopascals. Using a unique software-based architecture, Aixplorer is able to generate a shear wave, capture it and measure its speed resulting in the assessment of true tissue elasticity values in kilopascals. A colour-coded map displays these results in real time; stiff lesions appear in red with high kilopascal values, while soft lesions appear in blue with low values.

March 5, 2011

SuperSonic Imagine Reports Validation of Clinical Benefits of ShearWave™ Elastography, Demonstrating Increased Performance in Breast Cancer Diagnosis. Study Results with validation on European Sub-Population were presented at the European Congress of Radiology (Vienna) on March 4th during a conference symposium.

SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.

November 29, 2010

SuperSonic Imagine Raises €34.5 Million in Series C Financing to support application
development and commercial expansion at global level.

SuperSonic Imagine, the innovative ultrasound medical imaging company, announced today the completion of a €34.5 million Series C financing, to develop additional clinical applications and ramp-up global commercial operations.

November 25, 2010

SuperSonic Imagine signs exclusive U.S. breast ultrasound partnership agreement with Hologic, Inc.

SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. (Nasdaq: HOLX) to develop the breast ultrasound market in the United States. Under the terms of the agreement, Hologic will sell, install and service SuperSonic Imagine’s Aixplorer MultiWave™ ultrasound system exclusively to the breast care community in the United States. SuperSonic Imagine has retained U.S. rights for the commercialization of the Aixplorer ultrasound system in all other clinical applications to include; liver, thyroid, abdominal, musculoskeletal, gynecological and prostate imaging.

November 16, 2010

SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO

SuperSonic Imagine, the innovative ultrasound medical imaging company, is pleased to announce Gordon Waldron has been named as Executive Vice President and CFO. As a member of the board of directors, he will be responsible for driving all of SuperSonic Imagine’s key strategic and commercial partnerships as well as overseeing the company’s financial development plan.

April 23, 2010

SuperSonic Imagine unveils results of largest breast ultrasound clinical trial ever undertaken.

World Wide Breast Trial Results on ShearWave™ Elastography indicate technology could change lesion classification and reduce negative biopsies.

SuperSonic Imagine, the innovative medical imaging company based in Aix-en-Provence, France has unveiled some of the results of the largest clinical breast study ever undertaken in ultrasound imaging. The worldwide multicenter study, involving top clinicians in the breast radiology community, is assessing the clinical benefits of ShearWave™ Elastography in the ultrasonic evaluation of breast lesions.

March 4th 2010

ECR 2010 Press release

SuperSonic Imagine will be hosting a symposium :

World Wide Breast Trial Preliminary Results on ShearWave™ Elastography

and

MultiWave™ Technology introducing ShearWave™ Elastography
for kidney, liver, and thyroid applications.

December 11th 2009

Hans Barella has been nominated President of the Supervisory Board of
SuperSonic Imagine.

During its meeting of July 2nd 2009, the Supervisory Board of SuperSonic Imagine, young, innovative corporation, which was founded in 2005 by experts in the ultrasound medical imaging field, has nominated Hans Barella as President of the Supervisory Board.

November, 25th 2009

Press File

During the 95th annual meeting of the Radiological Society of North America

29th November 2009- 3rd December 2009.

August, 25th 2009

SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System

Innovative ShearWave Elastography and Impeccable Image Quality Bring New Levels of Diagnostic Capabilities to US Healthcare Market.

SuperSonic Imagine today announced that it has received 510K Clearance from the FDA for its Aixplorer™ ultrasound system and will begin to market and deliver the device in the United States.  Aixplorer is the only commercially available system of its kind with MultiWave™ Technology, which is based upon interaction between conventional longitudinal waves and shear waves in tissue.  The system consists of an all software-based architecture which provides both impeccable B-mode images and, for the first time, displays tissue stiffness or elasticity information using shear waves.  As stiffness is an additional parameter which characterizes tissue, Aixplorer brings clinicians significantly enhanced diagnostic information.

May 2009

SuperSonic Imagine concludes the extension of its second round of financing

SuperSonic Imagine announces the completion of a second round of fund-raising of €6 million with Wellington Partners and ICSO Private Equity.
Edmond de Rothschild Investment Partners was the leader in this fund-raising round that started in October 2008 with a global amount of €26 million.

January, 10th 2009

The medtech company THERACLION obtains €8.5 million in R&D funding from OSEO Innovation

October 23th, 2008

€20 million capital funding for SuperSonic Imagine, new French player in the medical world- revolutionizing the ultrasound market and defying the world’s giants

SuperSonic Imagine announces a second fund-raising round of €20 million, led by Edmond de Rothschild Investment Partners

October 16th, 2008

During the “Journées Françaises de Radiologie” 2008 (French Days of Radiology - JFR),
A revolutionary ultrasound system for breast imaging is being presented by: SuperSonic Imagine

A new French presence in the medical industry, shattering the ultrasound market, and challenging the giants of the field.